Role of SNAP‐25 MnlI variant in impaired working memory and brain functions in attention deficit/hyperactivity disorder

Abstract Introduction Attention deficit/hyperactivity disorder (ADHD) is a hereditary neurodevelopmental disorder characterized by working memory (WM) deficits. The MnlI variant (rs3746544) of the synaptosomal‐associated protein 25 (SNAP‐25) gene is associated with ADHD. In this study, we investigat...

Full description

Bibliographic Details
Published in:	Brain and Behavior
Main Authors:	Diangang Fang, Binrang Yang, Peng Wang, Tong Mo, Yungen Gan, Guohua Liang, Rong Huang, Hongwu Zeng
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Subjects:	ADHD brain function SNAP‐25 working memory
Online Access:	https://doi.org/10.1002/brb3.2758

Similar Items

Effects of the SNAP-25 Mnll variant on hippocampal functional connectivity in children with attention deficit/hyperactivity disorder
by: Wenxian Huang, et al.
Published: (2023-08-01)

Synaptosomal-Associated Protein 25 Gene Polymorphisms Affect Treatment Efficiency of Methylphenidate in Children With Attention-Deficit Hyperactivity Disorder: An fNIRS Study
by: Jie Li, et al.
Published: (2022-01-01)

Genetic Basis of Attention Deficit Hyperactivity Disorder
by: Nihal Yurteri, et al.
Published: (2011-01-01)

Attention Deficit Hyperactivity Disorder in Primary School Chiangmai, Thailand
by: Kesaraporn Choopun, et al.
Published: (2022-11-01)

SNAP-25 Polymorphisms in Autism Spectrum Disorder: A Pilot Study towards a Possible Endophenotype
by: Martina Maria Mensi, et al.
Published: (2023-12-01)

Engineering an Effective Human SNAP-23 Cleaving Botulinum Neurotoxin A Variant
by: Stefan Sikorra, et al.
Published: (2020-12-01)

SNAP-25 gene polymorphism and cognitive resource in patients with stroke sequels
by: V. B. Vilyanov, et al.
Published: (2016-03-01)

Sarcopenia associates with SNAP-25 SNPs and a miRNAs profile which is modulated by structured rehabilitation treatment
by: Simone Agostini, et al.
Published: (2021-07-01)

Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope
by: Adva Mechaly, et al.
Published: (2022-03-01)

Moniezia benedeni drives the SNAP-25 expression of the enteric nerves in sheep's small intestine
by: Zhen Huang, et al.
Published: (2024-07-01)

Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease
by: Johanna Nilsson, et al.
Published: (2022-06-01)

Muscone Protects Against Ferroptosis-Induced Injury in Models of Acute Ischemic Stroke by Modulating Snap25 Protein
by: Ruijia You, et al.
Published: (2025-06-01)

Detection of botulinum neurotoxin serotypes c and d, and their effects on expressions of snap-25 and synaptobrevin in ruminants: an immunohistochemical study
by: Mehmet Burak ATEŞ, et al.
Published: (2021-02-01)

Synaptic retrograde regulation of the PKA-induced SNAP-25 and Synapsin-1 phosphorylation
by: Aleksandra Polishchuk, et al.
Published: (2023-03-01)

Rabphilin 3A binds the N-peptide of SNAP-25 to promote SNARE complex assembly in exocytosis
by: Tianzhi Li, et al.
Published: (2022-09-01)

The destructive effect of botulinum neurotoxins on the SNARE protein: SNAP-25 and synaptic membrane fusion
by: Bin Lu
Published: (2015-06-01)

Construction of a Yeast Cell-Based Assay System to Analyze SNAP25-Targeting Botulinum Neurotoxins
by: Shilin Chen, et al.
Published: (2023-04-01)

Levels of Cortisol in CSF Are Associated With SNAP-25 and Tau Pathology but Not Amyloid-β
by: Qing Wang, et al.
Published: (2018-11-01)

Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias
by: Giuseppe Mario Bentivenga, et al.
Published: (2023-09-01)

SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
by: Qian Wang, et al.
Published: (2023-12-01)

Non-coding variants in VAMP2 and SNAP25 affect gene expression: potential implications in migraine susceptibility
by: Daniela Felício, et al.
Published: (2023-06-01)

Carbohydrate response element‐binding protein (ChREBP) mediates decreased SNAP25 expression in islets from diabetic Goto‐Kakizaki (GK) rats
by: Anyi Hu, et al.
Published: (2024-11-01)

Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
by: Pia Kivisäkk, et al.
Published: (2022-04-01)

A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25
by: Catherine Rhéaume, et al.
Published: (2015-06-01)

Iron and Ferritin Levels of Children and Adolescents with Attention Deficit Hyperactivity Disorder and Attention Deficit Hyperactivity Disorder-Not Otherwise Specified
by: Yusuf Öztürk, et al.
Published: (2020-09-01)

Neuronal-specific TNFAIP1 ablation attenuates postoperative cognitive dysfunction via targeting SNAP25 for K48-linked ubiquitination
by: Wei Wang, et al.
Published: (2023-12-01)

Rabphilin-3A negatively regulates neuropeptide release, through its SNAP25 interaction
by: Adlin Abramian, et al.
Published: (2024-10-01)

Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease
by: Lorenzo Gaetani, et al.
Published: (2025-05-01)

When Attention-Deficit/Hyperactivity Disorder reaches adulthood
by: A.S. Morais, et al.
Published: (2022-06-01)

Neurofeedback Training in the Treatment of Attention Deficit Hyperactivity Disorder
by: Ferhat Yaylacı, et al.
Published: (2019-12-01)

Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer’s pathophysiological biomarkers
by: Alba Cervantes González, et al.
Published: (2025-02-01)

Attention deficit hyperactivity disorder - symptoms, diagnosis and therapy among children and adults.
by: Agata Surowiec, et al.
Published: (2023-08-01)

Attention-deficit/hyperactivity disorder
by: A. M.E. du Plessis
Published: (2015-05-01)

Visual function and color vision in adults with Attention-Deficit/Hyperactivity Disorder
by: Soyeon Kim, et al.
Published: (2014-01-01)

Decision-making and attention deficit hyperactivity disorder: neuroeconomic perspective
by: Aisha Sanober Chachar, et al.
Published: (2024-10-01)

Attention-deficit hyperactivity disorder in adults: A guide for the general practitioner
by: G.I. van Schalkwyk, et al.
Published: (2011-04-01)

Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment
by: Altfas Jules R
Published: (2002-09-01)

Magnesium supplementation in children with attention deficit hyperactivity disorder
by: Farida El Baza, et al.
Published: (2016-01-01)

Screening for adult attention deficit and hyperactivity disorder among military parents: A pilot study
by: A. Ben Othman, et al.
Published: (2021-04-01)

Viloxazine: A New Non-Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD)
by: Wiktoria, et al.
Published: (2024-02-01)